MEDiSTRAVA
Brandon Boland, PhD has a diverse work experience. Brandon currently holds the position of Vice President, Biotechnology Portfolio Lead at MEDiSTRAVA. Before this, they served as Senior Director, Portfolio Lead in the same company. Prior to joining MEDiSTRAVA, Brandon worked as a Strategic Account Director and Strategic Account Manager at PRECISIONscientia. Brandon also has experience as a Key Account Manager and Senior Scientist at Gubra. Brandon's career began as a Postdoctoral Fellow at AstraZeneca / Medimmune. Brandon pursued their doctoral studies at the University of Chicago and also served as a Core Lab Manager at Baylor College of Medicine.
Brandon Boland, PhD received their B.S. in Biology from Southwestern University in 2007. Brandon then went on to complete their Doctor of Philosophy (PhD) in Molecular Metabolism at the University of Chicago from 2009 to 2015.
This person is not in any offices
MEDiSTRAVA
The real world is now a multi-dimensional universe of decision makers, evidence needs and healthcare systems requiring a connected, systematic and dynamic approach to medical and evidence planning, data dissemination, stakeholder engagement and education. The opportunity extends beyond traditional medical agency services to meet the growing and diversifying needs of medical affairs and finding integrated solutions in a fragmented and underserved market. We bring more than 20 years of experience in medical affairs with deep therapeutic expertise across oncology, specialised medicine and effecting change in chronic diseases. MEDiSTRAVA is part of Inizio Medical. Inizio is a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engagement services.